$BLNC
Balance Labs, Inc. Stock $blnc

$blnc Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000149315222033074 Filed on November 21, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$45.00K	$67.50K	$200.0K
YoY Change	-89.4%	-66.25%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$64.90K	$24.85K	$99.82K
YoY Change	-40.67%	-75.11%	15.52%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$0.00	$0.00
YoY Change			-100.0%
% of Gross Profit
Operating Expenses	$64.90K	$24.85K	$99.82K
YoY Change	-40.67%	-75.1%	15.52%
Operating Profit		$42.65K	$100.2K
YoY Change		-57.43%
Interest Expense	-$165.8K	$57.51K	$3.181M
YoY Change	-95.72%	-98.19%
% of Operating Profit		134.85%	3174.72%
Other Income/Expense, Net	-$10.71K	-$185.2K	$3.020M
YoY Change		-106.13%
Pretax Income	-$196.4K	-$142.6K	$3.121M
YoY Change	-94.49%	-104.57%	-1251.94%
Income Tax
% Of Pretax Income
Net Earnings	-$196.4K	-$142.6K	$3.129M
YoY Change	-94.49%	-104.56%	-1262.57%
Net Earnings / Revenue	-436.4%	-211.23%	1564.36%
Basic Earnings Per Share		$0.00	$0.14
Diluted Earnings Per Share	-$0.01	$0.00	$125.0K
COMMON SHARES
Basic Shares Outstanding	21.67M shares	21.67M shares	21.67M shares
Diluted Shares Outstanding		21.67M shares	25.04M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$384.1K	$515.3K	$222.3K
YoY Change	-50.6%	131.77%	4032.34%
Cash & Equivalents	$235.3K	$269.7K	$222.3K
Short-Term Investments	$148.8K	$245.5K
Other Short-Term Assets			$0.00
YoY Change			-100.0%
Inventory
Prepaid Expenses
Receivables	$45.00K	$22.50K
Other Receivables	$0.00	$21.96K
Total Short-Term Assets	$429.1K	$314.2K	$360.5K
YoY Change	0.81%	-12.84%	918.94%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles			$0.00
YoY Change
Long-Term Investments			$4.119M
YoY Change			2012.16%
Other Assets		$245.5K
YoY Change
Total Long-Term Assets	$0.00	$245.5K	$4.144M
YoY Change	-100.0%	-94.07%	1789.68%
TOTAL ASSETS
Total Short-Term Assets	$429.1K	$314.2K	$360.5K
Total Long-Term Assets	$0.00	$245.5K	$4.144M
Total Assets	$429.1K	$559.7K	$4.504M
YoY Change	-57.7%	-87.57%	1668.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.132M	$911.7K	$821.7K
YoY Change	150.3%	10.95%	17.1%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$1.699M	$1.699M	$1.674M
YoY Change	0.0%	1.49%	4.24%
Long-Term Debt Due	$280.0K	$280.0K	$274.9K
YoY Change	1.24%	1.89%
Total Short-Term Liabilities	$4.110M	$4.047M	$3.870M
YoY Change	4.36%	4.59%	19.86%
LONG-TERM LIABILITIES
Long-Term Debt	$480.2K	$477.3K	$466.0K
YoY Change	2.42%	2.43%	-0.68%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$480.2K	$477.3K	$466.0K
YoY Change	2.42%	2.43%	-0.68%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.110M	$4.047M	$3.870M
Total Long-Term Liabilities	$480.2K	$477.3K	$466.0K
Total Liabilities	$4.590M	$4.525M	$4.269M
YoY Change	4.15%	5.99%	17.1%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.974M	-$4.777M
YoY Change	18.27%
Common Stock	$2.167K	$2.167K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.161M	-$3.965M	$235.2K
YoY Change
Total Liabilities & Shareholders Equity	$429.1K	$559.7K	$4.504M
YoY Change	-57.7%	-87.57%	1668.71%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$196.4K	-$142.6K	$3.129M
YoY Change	-94.49%	-104.56%	-1262.57%
Depreciation, Depletion And Amortization	$0.00	$0.00	$0.00
YoY Change			-100.0%
Cash From Operating Activities	-$43.46K	$51.00K	$131.1K
YoY Change	1393.47%	-61.09%	-343.83%
INVESTING ACTIVITIES
Capital Expenditures	$0.00		$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$9.030K	-$9.030K	-$58.32K
YoY Change	-153.56%	-84.52%
Cash From Investing Activities	$9.030K	-$9.030K	-$58.32K
YoY Change	-153.56%	-84.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	40.00K
YoY Change	-100.0%	-100.0%	-21.57%
NET CHANGE
Cash From Operating Activities	-43.46K	51.00K	131.1K
Cash From Investing Activities	9.030K	-9.030K	-58.32K
Cash From Financing Activities	0.000	0.000	40.00K
Net Change In Cash	-34.43K	41.97K	112.7K
YoY Change	-758.32%	-62.77%	-4199.64%
FREE CASH FLOW
Cash From Operating Activities	-$43.46K	$51.00K	$131.1K
Capital Expenditures	$0.00		$0.00
Free Cash Flow	-$43.46K		$131.1K
YoY Change	1393.47%		-343.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001632121
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent		usd
CY2022Q3	us-gaap	Due From Related Parties Noncurrent DueFromRelatedPartiesNoncurrent		usd
CY2022Q3	us-gaap	Equity Method Investments EquityMethodInvestments		usd
CY2022Q3	BLNC	Accumulated Losses Of Unconsolidated Investees In Excess Of Investment AccumulatedLossesOfUnconsolidatedInvesteesInExcessOfInvestment		usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q3	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty		usd
CY2021Q3	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments		usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments		usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments		usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2021Q3	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee		usd
	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee		usd
CY2022Q3	BLNC	Gain On Forgiveness Of Ppp Loan GainOnForgivenessOfPPPLoan		usd
	BLNC	Gain On Forgiveness Of Ppp Loan GainOnForgivenessOfPPPLoan		usd
CY2022Q3	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount		usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount		usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Depreciation Depreciation		usd
	us-gaap	Amortization Of Regulatory Asset AmortizationOfRegulatoryAsset		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
	BLNC	Gain On Deconsolidation Of Subsidiary GainOnDeconsolidationOfSubsidiary		usd
	BLNC	Gain On Forgiveness Of Ppp Loan One GainOnForgivenessOfPPPLoanOne		usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
	BLNC	Payments To Related Party PaymentsToRelatedParty		usd
	BLNC	Cash Disposed In Deconsolidation Of Subsidiary CashDisposedInDeconsolidationOfSubsidiary		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	BLNC	Proceeds From Issuance Of Convertible Note Payable Related Party Net ProceedsFromIssuanceOfConvertibleNotePayableRelatedPartyNet		usd
	BLNC	Proceeds From Short Term Advances Related Parties ProceedsFromShortTermAdvancesRelatedParties		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	BLNC	Investment At Fair Value Received From Issuance Of Note Receivable InvestmentAtFairValueReceivedFromIssuanceOfNoteReceivable		usd
	BLNC	Beneficial Conversion Features On Convertible Notes Payable Related Party BeneficialConversionFeaturesOnConvertibleNotesPayableRelatedParty		usd
CY2021Q3	us-gaap	Business Combination Assets And Liabilities Arising From Contingencies Amount Recognized BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized		usd
CY2021Q3	us-gaap	Business Combination Assets And Liabilities Arising From Contingencies Amount Recognized Other Than At Fair Value BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue		usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2022Q3	us-gaap	Depreciation Depreciation		usd
CY2021Q3	us-gaap	Depreciation Depreciation		usd
	us-gaap	Depreciation Depreciation		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-202959
	dei	Entity Registrant Name EntityRegistrantName	BALANCE LABS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-1146785
	dei	Entity Address Address Line1 EntityAddressAddressLine1	407 Lincoln Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 701
	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami Beach
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33139
	dei	City Area Code CityAreaCode	(305)
	dei	Local Phone Number LocalPhoneNumber	907-7600
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21674000	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	269740	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	227558	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22500	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22500	usd
CY2022Q3	us-gaap	Interest Receivable Current InterestReceivableCurrent	21958	usd
CY2021Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	12932	usd
CY2022Q3	BLNC	Notes Receivable Unamortized Discount Current NotesReceivableUnamortizedDiscountCurrent	0	usd
CY2021Q4	BLNC	Notes Receivable Unamortized Discount Current NotesReceivableUnamortizedDiscountCurrent	3308	usd
CY2022Q3	BLNC	Notes Receivable Unamortized Allowance Current NotesReceivableUnamortizedAllowanceCurrent	141000	usd
CY2021Q4	BLNC	Notes Receivable Unamortized Allowance Current NotesReceivableUnamortizedAllowanceCurrent	0	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	162692	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	314198	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	425682	usd
CY2021Q4	us-gaap	Due From Related Parties Noncurrent DueFromRelatedPartiesNoncurrent	20000	usd
CY2022Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	245533	usd
CY2021Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	550057	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	18812	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	245533	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	588869	usd
CY2022Q3	us-gaap	Assets Assets	559731	usd
CY2021Q4	us-gaap	Assets Assets	1014551	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1157085	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1010028	usd
CY2022Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	911659	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	851659	usd
CY2022Q3	BLNC	Due To Related Parties Current Exclude Notes Payable Related Parties Classified DueToRelatedPartiesCurrentExcludeNotesPayableRelatedPartiesClassified	1673558	usd
CY2021Q4	BLNC	Due To Related Parties Current Exclude Notes Payable Related Parties Classified DueToRelatedPartiesCurrentExcludeNotesPayableRelatedPartiesClassified	1673558	usd
CY2022Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	25000	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	25000	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	3428	usd
CY2022Q3	BLNC	Due To Related Party Current DueToRelatedPartyCurrent	173192	usd
CY2021Q4	BLNC	Due To Related Party Current DueToRelatedPartyCurrent	169764	usd
CY2022Q3	BLNC	Notes Payable Unamortized Discount Current NotesPayableUnamortizedDiscountCurrent	0	usd
CY2021Q4	BLNC	Notes Payable Unamortized Discount Current NotesPayableUnamortizedDiscountCurrent	0	usd
CY2022Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	106850	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	106850	usd
CY2021Q4	BLNC	Accumulated Losses Of Unconsolidated Investees In Excess Of Investment AccumulatedLossesOfUnconsolidatedInvesteesInExcessOfInvestment	101838	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4047344	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3938697	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	22680	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	31185	usd
CY2022Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	477320	usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	468815	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	477320	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	468815	usd
CY2022Q3	us-gaap	Liabilities Liabilities	4524664	usd
CY2021Q4	us-gaap	Liabilities Liabilities	4407512	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21674000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21674000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21674000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21674000	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	2167	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	2167	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	810048	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	810048	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4777148	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4205176	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-3964933	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3392961	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3964933	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3392961	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	559731	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1014551	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	67500	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	200000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	202500	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	200000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4764	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7386	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16060	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25194	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	10000	usd
CY2021Q3	us-gaap	Professional Fees ProfessionalFees	28579	usd
	us-gaap	Professional Fees ProfessionalFees	85461	usd
	us-gaap	Professional Fees ProfessionalFees	69229	usd
CY2022Q3	us-gaap	Salaries And Wages SalariesAndWages	10090	usd
CY2021Q3	us-gaap	Salaries And Wages SalariesAndWages	33851	usd
	us-gaap	Salaries And Wages SalariesAndWages	43911	usd
	us-gaap	Salaries And Wages SalariesAndWages	106347	usd
CY2021Q3	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	30000	usd
	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	60000	usd
	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	90000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	24854	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	99816	usd
	us-gaap	Operating Expenses OperatingExpenses	205432	usd
	us-gaap	Operating Expenses OperatingExpenses	290770	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	42646	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	100184	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2932	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-90770	usd
CY2022Q3	us-gaap	Gain Or Loss On Sale Of Previously Unissued Stock By Equity Investee GainOrLossOnSaleOfPreviouslyUnissuedStockByEquityInvestee	-73054	usd
CY2021Q3	us-gaap	Gain Or Loss On Sale Of Previously Unissued Stock By Equity Investee GainOrLossOnSaleOfPreviouslyUnissuedStockByEquityInvestee	3090000	usd
	us-gaap	Gain Or Loss On Sale Of Previously Unissued Stock By Equity Investee GainOrLossOnSaleOfPreviouslyUnissuedStockByEquityInvestee	-304238	usd
	us-gaap	Gain Or Loss On Sale Of Previously Unissued Stock By Equity Investee GainOrLossOnSaleOfPreviouslyUnissuedStockByEquityInvestee	3069500	usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-287	usd
CY2021Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-19608	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-43812	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-72756	usd
CY2022Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	141000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	141000	usd
CY2022Q3	BLNC	Accreted Interest Income And Interest Income On Note Receivable AccretedInterestIncomeAndInterestIncomeOnNoteReceivable	3555	usd
CY2021Q3	BLNC	Accreted Interest Income And Interest Income On Note Receivable AccretedInterestIncomeAndInterestIncomeOnNoteReceivable	14739	usd
	BLNC	Accreted Interest Income And Interest Income On Note Receivable AccretedInterestIncomeAndInterestIncomeOnNoteReceivable	11110	usd
	BLNC	Accreted Interest Income And Interest Income On Note Receivable AccretedInterestIncomeAndInterestIncomeOnNoteReceivable	37479	usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	83064	usd
	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	83064	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	57507	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	58477	usd
	us-gaap	Interest Expense InterestExpense	174164	usd
	us-gaap	Interest Expense InterestExpense	184978	usd
CY2021Q3	BLNC	Impairment Of Investment ImpairmentOfInvestment	-195000	usd
	BLNC	Impairment Of Investment ImpairmentOfInvestment	-195000	usd
CY2021Q3	BLNC	Gain On Forgiveness Of Ppp Loan GainOnForgivenessOfPPPLoan	34759	usd
	BLNC	Gain On Forgiveness Of Ppp Loan GainOnForgivenessOfPPPLoan	34759	usd
CY2021Q3	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	153907	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	153907	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-185229	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3020320	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-569040	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2842911	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-142583	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	3120504	usd
	us-gaap	Profit Loss ProfitLoss	-571972	usd
	us-gaap	Profit Loss ProfitLoss	2752141	usd
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8204	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-12708	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-142583	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	3128708	usd
	us-gaap	Net Income Loss NetIncomeLoss	-571972	usd
	us-gaap	Net Income Loss NetIncomeLoss	2764849	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21674000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21674000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21674000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21674000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21674000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25039133	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21674000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21674000	shares
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3822350	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-142583	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3964933	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2951920	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	3120504	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	168584	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3392961	usd
	us-gaap	Profit Loss ProfitLoss	-571972	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3964933	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2587356	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2587356	usd
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	3799	usd
	us-gaap	Profit Loss ProfitLoss	2752141	usd
	us-gaap	Profit Loss ProfitLoss	2752141	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	168584	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	168584	usd
	us-gaap	Profit Loss ProfitLoss	-571972	usd
	us-gaap	Profit Loss ProfitLoss	2752141	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	11933	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	10305	usd
	BLNC	Amortization Of Expense On Note Receivable AmortizationOfExpenseOnNoteReceivable	3309	usd
	BLNC	Amortization Of Expense On Note Receivable AmortizationOfExpenseOnNoteReceivable	28530	usd
	us-gaap	Depreciation Depreciation	80	usd
	us-gaap	Amortization Of Regulatory Asset AmortizationOfRegulatoryAsset	1336	usd
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	195000	usd
	BLNC	Equity Method Investment Summarized Financial Information Net Loss EquityMethodInvestmentSummarizedFinancialInformationNetLoss	43812	usd
	BLNC	Equity Method Investment Summarized Financial Information Net Loss EquityMethodInvestmentSummarizedFinancialInformationNetLoss	14278	usd
	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-304524	usd
	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	3069500	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	141000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	83064	usd
	BLNC	Gain On Deconsolidation Of Subsidiary GainOnDeconsolidationOfSubsidiary	153907	usd
	BLNC	Gain On Forgiveness Of Ppp Loan One GainOnForgivenessOfPPPLoanOne	34500	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-25000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	147058	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	93716	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	60000	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	90000	usd
	BLNC	Increase Decrease In Accumulated Income Losses Of Unconsolidated Investees In Excess Of Investment IncreaseDecreaseInAccumulatedIncomeLossesOfUnconsolidatedInvesteesInExcessOfInvestment	-1226	usd
	BLNC	Increase Decrease In Accumulated Income Losses Of Unconsolidated Investees In Excess Of Investment IncreaseDecreaseInAccumulatedIncomeLossesOfUnconsolidatedInvesteesInExcessOfInvestment	-58478	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	51208	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-61883	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	119000	usd
	us-gaap	Payments To Acquire Retained Interest In Securitized Receivables PaymentsToAcquireRetainedInterestInSecuritizedReceivables	9026	usd
	us-gaap	Payments To Acquire Retained Interest In Securitized Receivables PaymentsToAcquireRetainedInterestInSecuritizedReceivables	7890	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9500	usd
	BLNC	Payments To Related Party PaymentsToRelatedParty	5142	usd
	BLNC	Cash Disposed In Deconsolidation Of Subsidiary CashDisposedInDeconsolidationOfSubsidiary	53178	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9026	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-194710	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-25000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	25000	usd
	BLNC	Proceeds From Issuance Of Convertible Note Payable Related Party Net ProceedsFromIssuanceOfConvertibleNotePayableRelatedPartyNet	50000	usd
	BLNC	Proceeds From Short Term Advances Related Parties ProceedsFromShortTermAdvancesRelatedParties	407500	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	457500	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	42182	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	216687	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	227558	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5632	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	269740	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	222319	usd
	us-gaap	Interest Paid Net InterestPaidNet	27218	usd
	us-gaap	Interest Paid Net InterestPaidNet	27782	usd
	BLNC	Investment At Fair Value Received From Issuance Of Note Receivable InvestmentAtFairValueReceivedFromIssuanceOfNoteReceivable	43000	usd
	BLNC	Beneficial Conversion Features On Convertible Notes Payable Related Party BeneficialConversionFeaturesOnConvertibleNotesPayableRelatedParty	3799	usd
CY2020Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.00
CY2022Q3	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	398592	shares
CY2022Q3	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	245533	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	51208	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	269740	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4777148	usd
CY2022Q3	BLNC	Working Capital Deficit WorkingCapitalDeficit	-3695211	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_843_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zSkqyUKjtUC" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86E_zW6OH0eDCOX2">Reclassification</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Non-controlling interest related to the deconsolidated of KryptoBank was re-classed to retained earnings. This reclassifications had no effect on the reported results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	48	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	2000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_z2aQGYsQ62G4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_868_z2PCQhrkvVQj">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Estimates may include those pertaining to stock-based compensation, depreciable lives of fixed assets and deferred tax assets. Actual results could materially differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BALANCE LABS, INC. <span style="text-transform: uppercase">and Subsidiaries</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to Consolidated Financial Statements</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2022</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.62
	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	304238	usd
	BLNC	Equity Method Investment Percentage Description EquityMethodInvestmentPercentageDescription	When the fair value of an investment is indeterminable, the Company accounts for its investments that are under 20% of the total equity outstanding using the cost method. For investments in which the Company holds between 20-50% equity and is non-controlling are accounted for using the equity method. For any investments in which the Company holds over 50% of the outstanding stock, the Company consolidates those entities into their condensed consolidated financial statements herein
CY2021	BLNC	Impairment Of Investment ImpairmentOfInvestment	-195000	usd
CY2020Q4	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	1000000	shares
CY2020Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1000000	usd
CY2021Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	0	usd
CY2022Q3	us-gaap	Investments Investments	0	usd
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	53178	usd
CY2021Q3	BLNC	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Trademark BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTrademark	2835	usd
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets	9500	usd
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	65513	usd
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	56489	usd
CY2021Q3	BLNC	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Due To Parent Company BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDueToParentCompany	25764	usd
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	25000	usd
CY2021Q3	BLNC	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Notes Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayable	112167	usd
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	219420	usd
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	153907	usd
CY2021Q3	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	153907	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zmN0Od8RTiP8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_860_zozpl6lg2zsf">Concentration of Credit Risk</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents and marketable securities. As of September 30, 2022, and December 31, 2021, the carrying value of marketable securities was $<span id="xdx_90F_eus-gaap--MarketableSecurities_iI_pp0p0_c20220930_zKyV0eAME6gi" title="Marketable securities">245,533</span> and $<span id="xdx_90A_eus-gaap--MarketableSecurities_iI_pp0p0_c20211231_zgxi4xOmftRi" title="Marketable securities">318,874</span>, respectively. The securities are included in the Investment at Fair Value – Related Party on the consolidated balance sheets, which consist of common shares held in one (1) investment which currently is trading on the Over-the-Counter Bulletin Board (OTCBB). On September 14, 2021, the S-1 Registration Statement for EZFill Holdings, Inc. was declared effective by Securities and Exchange Commission. The Company has reclassified this investment from Level 3 to Level 1 asset on the fair value hierarchy because the investment is valued based on quoted market price using observable inputs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	us-gaap	Marketable Securities MarketableSecurities	245533	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	318874	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	0	usd
CY2021	BLNC	Impairment Of Investment ImpairmentOfInvestment	-195000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	3730	usd
CY2022Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	48	usd
CY2021Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	401	usd
	us-gaap	Property Plant And Equipment Estimated Useful Lives PropertyPlantAndEquipmentEstimatedUsefulLives	three to five years
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11316	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11316	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11316	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11316	usd
	us-gaap	Depreciation Depreciation	80	usd
	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	9500	usd
CY2022Q3	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	0	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	BLNC	Allowance Receivable On Percentage AllowanceReceivableOnPercentage	1	pure
CY2022Q3	BLNC	Accreted Interest On Note Receivable AccretedInterestOnNoteReceivable	11244	usd
	BLNC	Accreted Interest On Note Receivable AccretedInterestOnNoteReceivable	8654	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	usd
CY2022Q3	us-gaap	Interest Income Related Party InterestIncomeRelatedParty	5343	usd
	us-gaap	Interest Income Related Party InterestIncomeRelatedParty	11244	usd
CY2016Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	72033	usd

Files In Submission

Name	View Source	Status
0001493152-22-033074-index-headers.html	Edgar Link	pending
0001493152-22-033074-index.html	Edgar Link	pending
0001493152-22-033074.txt	Edgar Link	pending
0001493152-22-033074-xbrl.zip	Edgar Link	pending
blnc-20220930.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
blnc-20220930_lab.xml	Edgar Link	unprocessable
blnc-20220930_cal.xml	Edgar Link	unprocessable
blnc-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
blnc-20220930_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BLNC
Balance Labs, Inc. Stock $blnc

2022 Q4 Form 10-Q Financial Statement

#000149315222033074 Filed on November 21, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLNC Balance Labs, Inc. Stock $blnc

2022 Q4 Form 10-Q Financial Statement

#000149315222033074 Filed on November 21, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLNC
Balance Labs, Inc. Stock $blnc